谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

TOWARDS THE LOWEST EFFICACIOUS DOSE (TOLEDO): RESULTS OF A MULTICENTER NON-INFERIORITY RANDOMIZED OPEN-LABEL CONTROLLED TRIAL ASSESSING TOCILIZUMAB OR ABATACEPT INJECTION SPACING IN RHEUMATOID ARTHRITIS PATIENTS IN REMISSION

Joanna Kedra,Philippe Dieude,Hubert Marotte,Alexandre Lafourcade,Emilie Ducourau,Thierry Schaeverbeke,Aleth Perdriger,Martin Soubrier,Jacques Morel,Arnaud Constantin,Emmanuelle Dernis,Valerie Royant,Jean-Hugues Salmon,Thao Pham,Jacques-Eric Gottenberg,Edouard Pertuiset,Maxime Dougados,Valerie Devauchelle Pensec,Philippe Gaudin,Gregoire Cormier,Philippe Goupille,Xavier Mariette,Francis Berenbaum,Didier Alcaix, Sid-Ahmed Rouidi,Jean-Marie Berthelot,Agnes Monnier,Christine Piroth,Frederic Liote,Vincent Goeb,Cecile Gaujoux-Viala,Isabelle Chary-Valckenaere,David Hajage,Florence Tubach,Bruno Fautrel

Poster presentations（2019）

引用 0|浏览2
关键词
rheumatoid arthritis patients,rheumatoid arthritis,lowest efficacious dose,abatacept injection spacing,non-inferiority,open-label
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要